Western blotting indicated that the TRAF3 mutation did not influence insulin signalling and TAK1–JNK/NF-κB pathways, unlike in TRAF3 (WT)-treated cells, and had a comparable effect on these molecular events to AdGFP infection (Fig. 9f). The gene discussed is NFKB1; the disease is infection.